Literature DB >> 28710148

Energy, Protein, Carbohydrate, and Lipid Intakes and Their Effects on Morbidity and Mortality in Critically Ill Adult Patients: A Systematic Review.

Anna Patkova1,2, Vera Joskova1,2, Eduard Havel3, Miroslav Kovarik1,2, Monika Kucharova4,2, Zdenek Zadak2, Miloslav Hronek5,2.   

Abstract

The guidelines for nutritional support in critically ill adult patients differ in various aspects. The optimal amount of energy and nutritional substrates supplied is important for reducing morbidity and mortality, but unfortunately this is not well known, because the topic is complex and every patient is individual. The aim of this review was to gather recent pertinent information concerning the nutritional support of critically ill patients in the intensive care unit (ICU) with respect to the energy, protein, carbohydrate, and lipid intakes and the effect of their specific utilization on morbidity and mortality. Enteral nutrition (EN) is generally recommended over parenteral nutrition (PN) and is beneficial when administered within 24-48 h after ICU admission. In contrast, early PN does not provide substantial advantages in terms of morbidity and mortality, and the time when it is safe and beneficial remains unclear. The most advantageous recommendation seems to be administration of a hypocaloric (<20 kcal · kg-1 · d-1), high-protein diet (amino acids at doses of ≥2 g · kg-1 · d-1), at least during the first week of critical illness. Another important factor for reducing morbidity is the maintenance of blood glucose concentrations at 120-150 mg/dL, which is accomplished with the use of insulin and lower doses of glucose of 1-2 g · kg-1 · d-1, because this prevents the risk of hypoglycemia and is associated with a better prognosis according to recent studies. A fat emulsion is used as a source of required calories because of insulin resistance in the majority of patients. In addition, lipid oxidation in these patients is ∼25% higher than in healthy subjects.
© 2017 American Society for Nutrition.

Entities:  

Keywords:  energy expenditure; energy metabolism; enteral nutrition; glucose control; indirect calorimetry; metabolism; parenteral nutrition; timing for nutrition commencement

Mesh:

Substances:

Year:  2017        PMID: 28710148      PMCID: PMC5502871          DOI: 10.3945/an.117.015172

Source DB:  PubMed          Journal:  Adv Nutr        ISSN: 2161-8313            Impact factor:   8.701


  104 in total

Review 1.  The stress response to trauma and surgery.

Authors:  J P Desborough
Journal:  Br J Anaesth       Date:  2000-07       Impact factor: 9.166

2.  Behind the ESPEN Guidelines on parenteral nutrition in the ICU.

Authors:  P Singer; H Shapiro; I Bendavid
Journal:  Minerva Anestesiol       Date:  2011-06-30       Impact factor: 3.051

Review 3.  Parenteral nutrition in the intensive care unit: cautious use improves outcome.

Authors:  Ronan Thibault; Claudia Paula Heidegger; Mette M Berger; Claude Pichard
Journal:  Swiss Med Wkly       Date:  2014-08-21       Impact factor: 2.193

Review 4.  Normocaloric versus hypocaloric feeding on the outcomes of ICU patients: a systematic review and meta-analysis.

Authors:  Paul E Marik; Michael H Hooper
Journal:  Intensive Care Med       Date:  2015-11-10       Impact factor: 17.440

Review 5.  Nutrition support for patients in the intensive care unit.

Authors:  R D Griffiths; T Bongers
Journal:  Postgrad Med J       Date:  2005-10       Impact factor: 2.401

6.  ESPEN Guidelines on Enteral Nutrition: Intensive care.

Authors:  K G Kreymann; M M Berger; N E P Deutz; M Hiesmayr; P Jolliet; G Kazandjiev; G Nitenberg; G van den Berghe; J Wernerman; C Ebner; W Hartl; C Heymann; C Spies
Journal:  Clin Nutr       Date:  2006-05-11       Impact factor: 7.324

7.  Early parenteral nutrition in critically ill patients with short-term relative contraindications to early enteral nutrition: a randomized controlled trial.

Authors:  Gordon S Doig; Fiona Simpson; Elizabeth A Sweetman; Simon R Finfer; D Jamie Cooper; Philippa T Heighes; Andrew R Davies; Michael O'Leary; Tom Solano; Sandra Peake
Journal:  JAMA       Date:  2013-05-22       Impact factor: 56.272

8.  ESPEN Guidelines on Parenteral Nutrition: intensive care.

Authors:  Pierre Singer; Mette M Berger; Greet Van den Berghe; Gianni Biolo; Philip Calder; Alastair Forbes; Richard Griffiths; Georg Kreyman; Xavier Leverve; Claude Pichard
Journal:  Clin Nutr       Date:  2009-06-07       Impact factor: 7.324

Review 9.  Glucose control in the intensive care unit: how it is done.

Authors:  Jane Harper
Journal:  Proc Nutr Soc       Date:  2007-08       Impact factor: 6.297

Review 10.  Timing of (supplemental) parenteral nutrition in critically ill patients: a systematic review.

Authors:  Rianne Bc Bost; Dave Ht Tjan; Arthur Rh van Zanten
Journal:  Ann Intensive Care       Date:  2014-10-02       Impact factor: 6.925

View more
  4 in total

Review 1.  Role of intestinal flora in colorectal cancer from the metabolite perspective: a systematic review.

Authors:  Shuwen Han; Jianlan Gao; Qing Zhou; Shanshan Liu; Caixia Wen; Xi Yang
Journal:  Cancer Manag Res       Date:  2018-01-31       Impact factor: 3.989

2.  Impact of protein intake and nutritional status on the clinical outcome of critically ill patients.

Authors:  Helânia Virginia Dantas Dos Santos; Izabelle Silva de Araújo
Journal:  Rev Bras Ter Intensiva       Date:  2019-05-30

3.  Lipid-Free PN is Associated with an Increased Risk of Hyperbilirubinemia in Surgical Critically Ill Patients with Admission Hepatic Disorder: A Retrospective Observational Study.

Authors:  Shih-Chi Wu; Te-An Chen; Han-Tsung Cheng; Yu-Jun Chang; Yu-Chun Wang; Chia-Wei Tzeng; Chia-Hao Hsu; Chih-Hsin Muo
Journal:  Ther Clin Risk Manag       Date:  2021-09-14       Impact factor: 2.423

4.  Protein delivery in intermittent and continuous enteral nutrition with a protein-rich formula in critically ill patients-a protocol for the prospective randomized controlled proof-of-concept Protein Bolus Nutrition (Pro BoNo) study.

Authors:  Simona Reinhold; Desirée Yeginsoy; Alexa Hollinger; Atanas Todorov; Lionel Tintignac; Michael Sinnreich; Caroline Kiss; Caroline E Gebhard; Balázs Kovács; Bianca Gysi; Lara Imwinkelried; Martin Siegemund
Journal:  Trials       Date:  2020-08-25       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.